US Patent 10966985 Macrocyclic compounds as ROS1 kinase inhibitors
Patent 10966985 was granted and assigned to Array Biopharma Inc. on April, 2021 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10966985 Macrocyclic compounds as ROS1 kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
